Cerep and Sanofi-Aventis in NPY1 receptor antagonist deal

 
• By Sita Shah
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category